Advertisement

Topics

Zyoxel Company Profile

19:07 EDT 18th September 2018 | BioPortfolio

Zyoxel has developed and fully commercialized the world’s most physiologically accurate in vitro 3D liver model. Their products and services are used by pharmaceutical companies to predict the clinical safety and pharmacological properties of new drugs. Zyoxel’s platform is based upon innovative technologies developed at the University of Oxford and the Massachusetts Institute of Technology. The company was spun out of Oxford University’s Institute of Biomedical Engineering in 2009 with investment from Hong Kong multinational CN Innovations Holdings.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Zyoxel

Zyoxel has developed and fully commercialized the world’s most physiologically accurate in vitro 3D liver model. Their products and services are used by pharmaceutical compan...

More Information about "Zyoxel" on BioPortfolio

We have published hundreds of Zyoxel news stories on BioPortfolio along with dozens of Zyoxel Clinical Trials and PubMed Articles about Zyoxel for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zyoxel Companies in our database. You can also find out about relevant Zyoxel Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...


Corporate Database Quicklinks



Searches Linking to this Company Record